APP and Alzheimer disease: We intended to construct a new drug screening cell model for AD, and focused the purpose of our study on two points: 1: Establishing gene knock in cell lines with a high gene modification efficiency and low unwanted off-target alteration rate.2: Constructing cell lines expressing APP at high levels that have reactivity to drugs that target key points in the amyloidogenic pathway or other pathways affecting APP metabolism.